PAR

1.92%

25.5¢ paradigm biopharmaceuticals limited..

agreed mozz...lets go then ...FDA approval is paramount. watch...

First 514 Last

Share
Profile

Follow
bobsee

233 Posts.

29

14/06/24

11:34

Post #: 74313814
Share

Originally posted by Mozzarc: ↑

Not arguing with you...it has seemed strange that we have had such good data and yet crickets. BUT...the industry has changed and in particular our sub sector. The scene is littered with failures after such big promises!

Now for some teeny weeny Aus company to go around proclaiming that we have it all....seems hard for anyone else to digest, specially that aren't fully across our drug and what it can do and it's distinct safety profile.

I remember at Oarsi the reactions were good, they were basically silenced into understanding what PAR were presenting. That was from the scientific community and that's a great start. Not a single person questioned any of the data, no one refuted it, no one brought up the possibility of negatives...no one argued out of some 900 that were there! All the convos I had were positive and I was there to the end watching and waiting for reactions. I talked to a lot from one edge of the spectrum to the other...basic just graduated researchers right to the very top of the entire game. Just me, one on one.

We need this to now translate into funding. We now have the data to begin conversations - The companies will start lining up...it will take one to move...if it isn't happening already, it will happen when a further material catalyst takes place.

Yes we are FT but we also need to genuinely be allowed to start a P3 and also another ray of light is TGA.

Get these and it will be the pivot we need.

Expand

agreed mozz...lets go then ...FDA approval is paramount. watch the interest ramp up then .

PAR Price at posting: 23.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

RCE

Recce's R327 found effective against E.coli during clinical trial

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

There are more pages in this discussion • 108 more messages in this thread...

First 514 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change -0.005(1.92%)		Mkt cap ! $89.19M

Open	High	Low	Value	Volume
27.0¢	27.0¢	25.5¢	$261.4K	990.7K

Buyers (Bids)

No.	Vol.	Price($)
1	9999	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	9445	1

View Market Depth

No.	Vol.	Price($)
1	9999	0.255
5	259000	0.250
4	96000	0.245
9	261374	0.240
5	71970	0.235

Price($)	Vol.	No.
0.260	9445	1
0.275	44000	2
0.280	35900	3
0.285	6729	2
0.290	60000	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

PAR (ASX) Chart

agreed mozz...lets go then ...FDA approval is paramount. watch...

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

agreed mozz...lets go then ...FDA approval is paramount. watch...

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News